Motamedi H, Mahdizade Ari M, Alvandi A, Abiri R
Front Microbiol. 2024; 15:1393646.
PMID: 38939184
PMC: 11208694.
DOI: 10.3389/fmicb.2024.1393646.
Hamidpour S, Amiri M, Haj Mohamad Ebrahim Ketabforoush A, Saeedi S, Angaji A, Tavakol S
Mol Neurobiol. 2024; 61(11):8928-8966.
PMID: 38573414
DOI: 10.1007/s12035-024-04128-1.
Lambourne O, Bell S, Wilhelm L, Yarbrough E, Holly G, Russell O
J Med Chem. 2023; 66(11):7645-7656.
PMID: 37248632
PMC: 10258795.
DOI: 10.1021/acs.jmedchem.3c00555.
Zhu S, Xu N, Han Y, Ye X, Yang L, Zuo J
Acta Biochim Biophys Sin (Shanghai). 2022; 54(8):1113-1121.
PMID: 35904214
PMC: 9828133.
DOI: 10.3724/abbs.2022098.
Feles S, Overath C, Reichardt S, Diegeler S, Schmitz C, Kronenberg J
Methods Protoc. 2022; 5(4).
PMID: 35893584
PMC: 9326679.
DOI: 10.3390/mps5040058.
Japanese Encephalitis Virus NS4A Protein Interacts with PTEN-Induced Kinase 1 (PINK1) and Promotes Mitophagy in Infected Cells.
Agarwal A, Alam M, Basu B, Pattanayak S, Asthana S, Syed G
Microbiol Spectr. 2022; 10(3):e0083022.
PMID: 35604158
PMC: 9241661.
DOI: 10.1128/spectrum.00830-22.
Targeting PINK1 Using Natural Products for the Treatment of Human Diseases.
Li Y, Zhang F, Yu L, Mu J, Yang Y, Yu J
Biomed Res Int. 2021; 2021:4045819.
PMID: 34751247
PMC: 8572127.
DOI: 10.1155/2021/4045819.
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease.
Magnusen A, Hatton S, Rani R, Pandey M
Front Neurol. 2021; 12:636139.
PMID: 34239490
PMC: 8259624.
DOI: 10.3389/fneur.2021.636139.
Maackiain Ameliorates 6-Hydroxydopamine and Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in and the SH-SY5Y Cell Line.
Tsai R, Tsai C, Liu S, Gao J, Kuo Y, Chao P
Int J Mol Sci. 2020; 21(12).
PMID: 32585871
PMC: 7352553.
DOI: 10.3390/ijms21124455.
Chronic treatment with the complex I inhibitor MPP depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6).
Verma M, Zhu J, Wang K, Chu C
J Biol Chem. 2020; 295(23):7865-7876.
PMID: 32332095
PMC: 7278356.
DOI: 10.1074/jbc.RA119.010474.
PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons.
Wang K, Steer E, Otero P, Bateman N, Cheng M, Scott A
eNeuro. 2019; 5(6).
PMID: 30783609
PMC: 6377406.
DOI: 10.1523/ENEURO.0466-18.2018.
Parkinson's disease: what the model systems have taught us so far.
Ghatak S, Trudler D, Dolatabadi N, Ambasudhan R
J Genet. 2018; 97(3):729-751.
PMID: 30027906
PINK1 regulates mitochondrial trafficking in dendrites of cortical neurons through mitochondrial PKA.
Banerjee T, Dagda R, Dagda M, Chu C, Rice M, Vazquez-Mayorga E
J Neurochem. 2017; 142(4):545-559.
PMID: 28556983
PMC: 5554084.
DOI: 10.1111/jnc.14083.
[PINK1 and the related diseases].
Huang Y, Mu D
Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(8):781-6.
PMID: 27530800
PMC: 7399510.
PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation.
Choi I, Woo J, Jou I, Joe E
Exp Neurobiol. 2016; 25(1):14-23.
PMID: 26924929
PMC: 4766110.
DOI: 10.5607/en.2016.25.1.14.
PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes.
Choi I, Choi D, Yang H, Woo J, Chang M, Kim J
Mol Brain. 2016; 9:5.
PMID: 26746235
PMC: 4706723.
DOI: 10.1186/s13041-016-0186-6.
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.
Mukherjee U, Ong S, Ong S, Hausenloy D
Pharmacol Ther. 2015; 156:34-43.
PMID: 26481155
PMC: 4667215.
DOI: 10.1016/j.pharmthera.2015.10.005.
Long noncoding RNAs in diseases of aging.
Kim J, Kim K, Noh J, Yoon J, Abdelmohsen K, Gorospe M
Biochim Biophys Acta. 2015; 1859(1):209-21.
PMID: 26141605
PMC: 4698248.
DOI: 10.1016/j.bbagrm.2015.06.013.
New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.
Trudler D, Nash Y, Frenkel D
J Neural Transm (Vienna). 2015; 122(10):1409-19.
PMID: 25894287
DOI: 10.1007/s00702-015-1399-z.
Emerging modes of PINK1 signaling: another task for MARK2.
Matenia D, Mandelkow E
Front Mol Neurosci. 2014; 7:37.
PMID: 24847206
PMC: 4021145.
DOI: 10.3389/fnmol.2014.00037.